Cargando…
Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy
BACKGROUND: Ketamine has been recently approved to treat resistant depression; however preclinical studies showed sex differences in its efficacy. Sex steroids, such as estrogens and testosterone, both in the periphery and locally in the brain, are regarded as important modulators of these sex diffe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599051/ https://www.ncbi.nlm.nih.gov/pubmed/37876000 http://dx.doi.org/10.1186/s13293-023-00560-5 |
_version_ | 1785125693166714880 |
---|---|
author | Ledesma-Corvi, Sandra Jornet-Plaza, Jordi García-Fuster, M. Julia |
author_facet | Ledesma-Corvi, Sandra Jornet-Plaza, Jordi García-Fuster, M. Julia |
author_sort | Ledesma-Corvi, Sandra |
collection | PubMed |
description | BACKGROUND: Ketamine has been recently approved to treat resistant depression; however preclinical studies showed sex differences in its efficacy. Sex steroids, such as estrogens and testosterone, both in the periphery and locally in the brain, are regarded as important modulators of these sex differences. Therefore, the present study evaluated how inhibiting the biosynthesis of estrogens with letrozole (an aromatase inhibitor) could affect the observed sex differences in ketamine's antidepressant-like-response. METHODS: We performed several consecutive studies in adult Sprague–Dawley rats to evaluate potential sex differences in the antidepressant-like effects of ketamine (5 mg/kg, 7 days, i.p.), letrozole (1 mg/kg, 8 days, i.p.) and their combination (letrozole pre-treatment 3 h before ketamine). Acute and repeated antidepressant-like responses were ascertained in a series of behavioral tests (forced-swim, novelty-suppressed feeding, two-bottle choice for sucrose preference). RESULTS: The main results proved clear sex differences in the antidepressant-like response induced by ketamine, which was observed following a repeated paradigm in adult male rats, but rendered inefficacious in female rats. Moreover, decreasing estrogens production with letrozole induced on itself an antidepressant-like response in female rats, while also increased ketamine's response in male rats (i.e., quicker response observed after only a single dose). Interestingly, both the antidepressant-like effects induced by ketamine in male rats or letrozole in female rats persisted over time up to 65 days post-treatment, suggesting long-term sex-directed benefits for these drugs. CONCLUSIONS: The present results demonstrated a sex-specific role for aromatase inhibition with letrozole in the antidepressant-like response induced by ketamine in male rats. Moreover, letrozole itself presented as a potential antidepressant for females with persistent effects over time. Clearly, the production of estrogens is key in modulating, in a sex-specific manner, affective-like responses and thus deserve further studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13293-023-00560-5. |
format | Online Article Text |
id | pubmed-10599051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105990512023-10-26 Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy Ledesma-Corvi, Sandra Jornet-Plaza, Jordi García-Fuster, M. Julia Biol Sex Differ Research BACKGROUND: Ketamine has been recently approved to treat resistant depression; however preclinical studies showed sex differences in its efficacy. Sex steroids, such as estrogens and testosterone, both in the periphery and locally in the brain, are regarded as important modulators of these sex differences. Therefore, the present study evaluated how inhibiting the biosynthesis of estrogens with letrozole (an aromatase inhibitor) could affect the observed sex differences in ketamine's antidepressant-like-response. METHODS: We performed several consecutive studies in adult Sprague–Dawley rats to evaluate potential sex differences in the antidepressant-like effects of ketamine (5 mg/kg, 7 days, i.p.), letrozole (1 mg/kg, 8 days, i.p.) and their combination (letrozole pre-treatment 3 h before ketamine). Acute and repeated antidepressant-like responses were ascertained in a series of behavioral tests (forced-swim, novelty-suppressed feeding, two-bottle choice for sucrose preference). RESULTS: The main results proved clear sex differences in the antidepressant-like response induced by ketamine, which was observed following a repeated paradigm in adult male rats, but rendered inefficacious in female rats. Moreover, decreasing estrogens production with letrozole induced on itself an antidepressant-like response in female rats, while also increased ketamine's response in male rats (i.e., quicker response observed after only a single dose). Interestingly, both the antidepressant-like effects induced by ketamine in male rats or letrozole in female rats persisted over time up to 65 days post-treatment, suggesting long-term sex-directed benefits for these drugs. CONCLUSIONS: The present results demonstrated a sex-specific role for aromatase inhibition with letrozole in the antidepressant-like response induced by ketamine in male rats. Moreover, letrozole itself presented as a potential antidepressant for females with persistent effects over time. Clearly, the production of estrogens is key in modulating, in a sex-specific manner, affective-like responses and thus deserve further studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13293-023-00560-5. BioMed Central 2023-10-24 /pmc/articles/PMC10599051/ /pubmed/37876000 http://dx.doi.org/10.1186/s13293-023-00560-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ledesma-Corvi, Sandra Jornet-Plaza, Jordi García-Fuster, M. Julia Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title | Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title_full | Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title_fullStr | Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title_full_unstemmed | Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title_short | Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
title_sort | aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599051/ https://www.ncbi.nlm.nih.gov/pubmed/37876000 http://dx.doi.org/10.1186/s13293-023-00560-5 |
work_keys_str_mv | AT ledesmacorvisandra aromataseinhibitionandketamineinratssexdifferencesinantidepressantlikeefficacy AT jornetplazajordi aromataseinhibitionandketamineinratssexdifferencesinantidepressantlikeefficacy AT garciafustermjulia aromataseinhibitionandketamineinratssexdifferencesinantidepressantlikeefficacy |